CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-17 | Molineaux Christopher P. Director | Exercise or conversion · Stock option (right to buy) | −6,702 | 1,993 | ||
| 2017-03-17 | Molineaux Christopher P. Director | Exercise or conversion · Stock option (right to buy) | −592 | 462 | ||
| 2017-03-17 | Molineaux Christopher P. Director | Exercise or conversion · Stock option (right to buy) | −311 | 171 | ||
| 2017-03-02 | VIVO VENTURES VII, LLC 10% owner | Sale | −122,334 | $31.20 | $3.8M | 2,797,597 |
| 2017-03-02 | VIVO VENTURES VII, LLC 10% owner | Sale | −2,666 | $31.20 | $83K | 60,972 |
| 2017-03-01 | VIVO VENTURES VII, LLC 10% owner | Sale | −97,867 | $30.98 | $3.0M | 2,919,931 |
| 2017-03-01 | VIVO VENTURES VII, LLC 10% owner | Sale | −2,133 | $30.98 | $66K | 63,638 |
| 2017-02-28 | VIVO VENTURES VII, LLC 10% owner | Sale | −195,734 | $30.50 | $6.0M | 3,017,798 |
| 2017-02-28 | VIVO VENTURES VII, LLC 10% owner | Sale | −4,266 | $30.50 | $130K | 65,771 |
| 2017-01-25 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2017-01-10 | Mehra Anand Director | Sale | −750,000 | $28.25 | $21.2M | 1,539,480 |
| 2016-12-19 | FMR LLC | Other disposition | −639,627 | 1,931,727 | ||
| 2016-12-18 | Powala Christopher Chief Operating Officer | Exercise or conversion | +1,625 | 132,059 | ||
| 2016-12-18 | Powala Christopher Chief Operating Officer | Shares withheld for taxes | −494 | $31.25 | $15K | 131,565 |
| 2016-12-18 | Powala Christopher Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −1,625 | 4,875 | ||
| 2016-12-18 | Ruffo Frank Chief Financial Officer | Exercise or conversion | +1,250 | 143,952 | ||
| 2016-12-18 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −380 | $31.25 | $12K | 143,572 |
| 2016-12-18 | Ruffo Frank Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,250 | 3,750 | ||
| 2016-12-18 | Ali-Jackson Kamil Chief Legal Officer | Exercise or conversion | +1,075 | 77,032 | ||
| 2016-12-18 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −327 | $31.25 | $10K | 76,705 |
Page 50 of 57 · 1,130 trades